Autor/in Blauvelt, A 1 Cichanowitz, N Gooderham, M Kimball, A B 1 La Rosa, C 1 Li, Q 1 Papp, K A 1 Reich, K alle zeigenListe einklappen
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies Kimball, A B Papp, K A Reich, K Gooderham, M Li, Q Cichanowitz, N La Rosa, C 2020 - Forschungsinformationssystem des UKE
